ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹604 Cr | ₹512 Cr | ₹475 Cr | ₹405 Cr | ₹398 Cr |
What is the latest Total Liabilities ratio of ALBERT DAVID ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹604 Cr |
Mar2023 | ₹512 Cr |
Mar2022 | ₹475 Cr |
Mar2021 | ₹405 Cr |
Mar2020 | ₹398 Cr |
How is Total Liabilities of ALBERT DAVID Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹604 Cr | 17.98 | |
Mar2023 | ₹512 Cr | 7.82 | |
Mar2022 | ₹475 Cr | 17.24 | |
Mar2021 | ₹405 Cr | 1.78 | |
Mar2020 | ₹398 Cr | - |
Compare Total Liabilities of peers of ALBERT DAVID
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALBERT DAVID | ₹459.2 Cr | 0.4% | -2% | -30.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,076.0 Cr | 0.3% | -4.9% | 15.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,924.0 Cr | 0.2% | 10% | 53.5% | Stock Analytics | |
CIPLA | ₹121,456.0 Cr | 2.3% | 1.1% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,197.0 Cr | 5.7% | 15% | 11.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,761.0 Cr | 0.8% | -0.9% | 17.4% | Stock Analytics |
ALBERT DAVID Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALBERT DAVID | 0.4% |
-2% |
-30.8% |
SENSEX | 0.9% |
1.8% |
11.1% |
You may also like the below Video Courses